PeptidePedia The community reference

Shanghai Sigma-Audley New Material Technology: difference between revisions

Diff·revision 24 → 25·03:41, 23 Feb 2025

Difference between revision 24 and revision 25 of Shanghai Sigma-Audley New Material Technology. 3 lines changed; the page grew by 295 bytes.

Revision 24 — 05:24, 17 Feb 2025
CheckSumChase (talk)
split overlong sentence
6,300 bytes ±0
Revision 25 — 03:41, 23 Feb 2025
LipidLedgerLou (talk)
rm citation to a supplier's own page
6,595 bytes +295
1{{Infobox organisation1{{Infobox organisation
2| name = Shanghai Sigma-Audley New Material Technology Co., Ltd.2| name = Shanghai Sigma-Audley New Material Technology Co., Ltd.
+3| subtitle = Organisation
3| image = facility.svg4| image = facility.svg
4| caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.5| caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.
40| SARMs | Bulk and capsuled | Certificate, variable detail |41| SARMs | Bulk and capsuled | Certificate, variable detail |
41| Injectable oils and raw materials | Bulk | Certificate, limited detail |42| Injectable oils and raw materials | Bulk | Certificate, limited detail |
+43
+44Documentation detail reported by purchasers is markedly better for the incretin analogues than for the bulk categories, a gradient visible across most organisations covered on this wiki and probably reflecting where purchaser scrutiny is concentrated.{{r|reports}}
4245
43== References ==46== References ==